Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2026-04-08 16:16:24 ET · period of report 2026-04-06 · accession 0001480212-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 16:16 | 2026-04-06 | SANA | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +7,763 | 5.85M | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-06 | A | A | 7,763 | $0.00 | 5,848,503 | D | — | — | (F1) Consists of fully vested restricted stock units. |